Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Field labs saved from ORA ax

This article was originally published in The Silver Sheet

Executive Summary

FDA's Office of Regulatory Affairs (ORA) is backing off plans to close seven field labs as part of an ongoing reorganization. Associate Commissioner for Regulatory Affairs Margaret O'K. Glavin sent ORA staff an e-mail Aug. 17 that said she was "canceling plans for the rollout of all changes in our organizational structure." However, she said this move would provide "additional time" to "take a fresh look at the challenges facing" the office. ORA's field labs inspect and analyze devices, food, drugs, animal medications and feeds, and other health products. The decision to call off the closure of seven of the office's 13 field labs was first indicated in an Aug. 1 e-mail to staff





Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts